Skip to content

Aidoc Alternatives: Clinical AI Platforms Compared

Aidoc sells a platform, not a single algorithm: an aiOS layer that organizes and delivers AI models inside existing clinical workflows, spanning radiology, vascular, neurology, and cardiology, with Care Coordination and Patient Management components, a systems-integration program, a partner model ecosystem, and an AI PATH program for strategy and rollout. Its listing here does not publish subscription pricing, which is normal for enterprise clinical AI — every tool on this page is quote-based. So the real choice is architectural: a multi-condition platform like Aidoc, a coordination-first system built around getting the right specialist moving (Viz.ai), a detection vendor with unusually broad cleared indications (Qure.ai), a cancer-screening and oncology specialist (Lunit), or the deepest possible answer on exactly one disease (Heartflow).

Quick answer

Stay with Aidoc if you want one governed platform carrying many models across service lines. Choose Viz.ai if care coordination — alerting the on-call specialist with images and clinical data in hand — is the bottleneck you are fixing. Choose Qure.ai if you want detection across chest X-ray, CT, and head CT with 26 FDA-cleared indications behind it. Choose Lunit if your program is cancer screening and oncology. Choose Heartflow if the question is coronary artery disease and you want FFRct, roadmap, and plaque analysis from a single CCTA study. None of these listings publishes pricing, so expect an enterprise quote process and a pilot whichever way you go.

What to look for

  • •Breadth vs. depth: one platform carrying many models, or a specialist that goes deeper in a single pathway.
  • •Coordination, not just detection: whether alerts reach the right clinician with images and data attached.
  • •Cleared indications: count the regulatory clearances that match your service lines; treat performance numbers as study- or vendor-reported until your own validation confirms them.
  • •Integration model: how models reach your PACS, EHR, and messaging workflows.
  • •Pricing transparency: none of these listings publishes prices, so budget for an enterprise sales process and a pilot.
ToolPricingFree to useAPIOpen sourceCompliance
Viz.aiPaidNoYes——
Qure.aiPaidNoYes——
LunitPaidNoYes——
HeartFlowPaidNoYes——

A dash means the vendor does not state this publicly.

Recommended alternatives

The closest architectural rival: detection plus care coordination in one system. It detects critical findings such as large vessel occlusion and pushes mobile alerts — carrying images and clinical data — to the on-call specialist, across Neuro, Cardio, Radiology, and Trauma suites, with Viz One for system-wide rollout. The company reports more than 2,000 hospitals use it (vendor-reported). Pricing is not published; API support is marked as available. Best when minutes-to-specialist is the metric you are buying.

Detection-first, organized by modality: qXR for chest X-ray, qCT for CT, and qER for head CT, covering lung nodules, intracranial hemorrhage, pneumothorax, and pleural effusion, with 26 FDA-cleared indications. Its listing cites a published study reporting up to 96% sensitivity and 100% specificity for pneumothorax and pleural effusion on qXR — a study result on a specific task, not a blanket claim. Pricing is not published; API support is marked as available. Best for high-volume imaging triage.

An oncology specialist: cancer-screening AI for radiology plus precision-oncology work reading the tumor microenvironment (its listing notes new lung-cancer TME insights announced at WCLC 2026) and biopharma partnerships. Its listing here is comparatively thin — no specific performance metrics and no pricing published — so evaluation leans on direct diligence; API support is marked as available. Best when your program starts and ends with cancer detection and oncology decision support.

The depth extreme: coronary artery disease analyzed from a standard coronary CT angiogram — FFRct Analysis, Roadmap Analysis (a personalized 3D model), and Plaque Analysis, with PCI Navigator for intervention planning. Commercially available in the US, with select functionality in the EU, UK, Japan, and Canada. Its listing carries ISO 13485 and SOC certifications; pricing is not published; API support is marked as available. Best for a complete coronary assessment pathway.

Frequently asked questions

How much does Aidoc cost?

Aidoc's listing does not publish subscription pricing, and neither do any of the alternatives on this page. Clinical AI at this level is sold through enterprise agreements, so expect a quote process and a pilot before any commitment.

What is the closest alternative to Aidoc?

Viz.ai — it pairs detection with care coordination across multiple suites (Neuro, Cardio, Radiology, Trauma) and offers Viz One for system-wide deployment, the same platform shape as Aidoc with a coordination-first emphasis.

Which alternative has the most FDA clearances?

Of the tools listed here, Qure.ai states the broadest clearance footprint: 26 FDA-cleared indications across its qXR, qCT, and qER products. Verify the specific indications you need against current regulatory listings during diligence.

Can these tools integrate with hospital systems?

Each of the four alternatives marks API support as available on its detail page here, and Aidoc runs a dedicated systems-integration program. The real question for your diligence is which systems — PACS, EHR, messaging — each vendor connects to in your environment.